Effect of Conjugated Linoleic Acid Supplement on Body Composition

Completed · Not applicable

Conditions studied: Obesity

In brief

The purpose of this clinical trial is to examine the effects of a low and high dose of conjugated linoleic acid supplement on body composition in obese humans. Individuals with a body mass index between 30 and 35kg/m2 are randomized to receive either placebo, 3.2gCLA, or 6.4g CLA daily for twelve weeks. Changes in body composition, weight, and clinical laboratory values are compared between the three groups.

Key facts

Study ID

NCT00347373

Run by

University of North Carolina

People needed

60

Starts

2004-08-01

Expected to finish

2005-09-01

Last updated by the study team

2006-07-04

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI between 30 and 35 kg/m2

You may not qualify if…

• history of chronic disease
• food allergies or intolerances
• drug therapy for diagnosed disease or lipid-lowering
• use of weight-lowering medication or diet
• use of tobacco products
• current or planned pregnancy
• use of CLA supplement in previous 3 months
• current substance abuse
• abnormal clinical laboratory values

Where it is running

• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.